TABLE 1.
Aphasia diagnoses and underlying pathology for the cohort
| No. (%) | |
|---|---|
| Total no. of pts |
289 (100) |
| Pathology |
|
| HGG |
142 (49.1) |
| LGG |
97 (33.6) |
| Epilepsy |
35 (12.1) |
| Brain metastases |
11 (3.8) |
| Other |
4 (1.4) |
| WAB classification on POD 2 |
289 |
| WNL |
106 (36.7) |
| Anomia |
102 (35.3) |
| Wernicke’s aphasia |
20 (6.9) |
| Broca’s aphasia |
19 (6.6) |
| Conduction |
14 (4.8) |
| Global aphasia |
14 (4.8) |
| Transcortical sensory |
7 (2.4) |
| Transcortical motor |
6 (2.1) |
| Isolation |
1 (0.3) |
| WAB classification at 1 mo |
178 |
| WNL |
136 (76.4) |
| Anomia |
38 (21.3) |
| Transcortical sensory |
2 (1.1) |
| Conduction | 2 (1.1) |
POD 2 = postoperative day 2; pts = patients; WNL = within normal limits. Epilepsy was defined as mesial temporal sclerosis, focal cortical dysplasia, gliosis, or nonspecific pathology in the clinical setting of epilepsy. HGGs were defined as WHO grade III or higher, and LGGs were defined as WHO grade II or lower.